News

Published on 2 Dec 2023 on Simply Wall St. via Yahoo Finance

Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago


Article preview image

uniQure N.V. (NASDAQ:QURE) shareholders should be happy to see the share price up 24% in the last month. But that doesn't change the fact that the returns over the last three years have been stomach churning. The share price has sunk like a leaky ship, down 86% in that time. So it sure is nice to see a bit of an improvement. But the more important question is whether the underlying business can justify a higher price still. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.

So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.

See our latest analysis for uniQure

NASDAQ.QURE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday’s...

Shares of Butterfly Network, Inc. BFLY fell sharply during Thursday’s session after the company...

Benzinga 29 Feb 2024

12 Best Medical Stocks to Buy Under $10

In this article, we will take a look at the 12 best medical stocks to buy under $10. To skip our ...

Insider Monkey via Yahoo Finance 27 Feb 2024

12 Best Genomics Stocks To Buy Now

In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip...

Insider Monkey via Yahoo Finance 10 Dec 2023

Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago

uniQure N.V. (NASDAQ:QURE) shareholders should be happy to see the share price up 24% in the last...

Simply Wall St. via Yahoo Finance 2 Dec 2023

Calculating The Fair Value Of uniQure N.V. (NASDAQ:QURE)

Key Insights The projected fair value for uniQure is US$7.03 based on 2 Stage Free Cash Flow to E...

Simply Wall St. via Yahoo Finance 11 Nov 2023

Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback

It was a busy week for the biotech sector. M&A is back in the spotlight in the sector as Bristol ...

Zacks via Yahoo Finance 12 Oct 2023

uniQure (QURE) Up on Restructuring Plans, Workforce Reduction

Shares of uniQure N.V. QURE were up 11.61% on Oct 5 after the company announced a strategic reorg...

Zacks via Yahoo Finance 6 Oct 2023

In the wake of uniQure N.V.'s (NASDAQ:QURE) latest US$36m market cap drop, institutional owners may...

Key Insights Institutions' substantial holdings in uniQure implies that they have significant inf...

Simply Wall St. via Yahoo Finance 5 Oct 2023

Analysts Are More Bearish On uniQure N.V. (NASDAQ:QURE) Than They Used To Be

The latest analyst coverage could presage a bad day for uniQure N.V. (NASDAQ:QURE), with the anal...

Simply Wall St. via Yahoo Finance 6 Aug 2023

uniQure (QURE) Falls on Mixed Huntington's Disease Study Results

uniQure Inc. QURE announced interim results from its ongoing phase I/II study of AMT-130 for the ...

Zacks via Yahoo Finance 22 Jun 2023